🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "specific action to tackle cost of living issues" in next month's financial statement.

Speaking to media outlets, she stated that curbing price rises is a shared responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the G7 advanced economies this year and the following year.

Possible Utility Bill Interventions

Sources suggest the government could intervene to lower utility costs, for example by reducing the current 5% level of value-added tax applied on energy supplies.

An additional approach is to lower some of the government charges currently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for these measures.

The view from most economists is that Reeves will have to introduce higher taxes or expenditure reductions in order to meet her declared borrowing rules.

Previously on Thursday, analysis suggested there was a twenty-two billion pound deficit for the Treasury chief to resolve, which is at the lower end of expectations.

"It is a collective task between the Bank of England and the government to bear down further on some of the sources of inflation," Reeves informed the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Issues

While much of the attention has been on likely tax rises, the chancellor said the most recent data from the OBR had not altered her commitment to campaign commitments not to increase rates on income tax, sales tax or National Insurance.

She blamed an "uncertain world" with growing international and trade issues for the Budget tax moves, likely to be focused on those "most able to pay."

International Trade Tensions

Commenting on worries about the United Kingdom's trade ties with the Asian nation she said: "Our security interests always are paramount."

Last week's declaration by China to strengthen export controls on rare earths and other materials that are essential for high-technology manufacturing led American leader Donald Trump to propose an further 100% import tax on imports from the Asian country, increasing the prospect of an all-out trade war between the two economic giants.

The American finance chief called the Chinese decision "commercial pressure" and "a international production control attempt."

Inquired about accepting the US offer to join its dispute with China, Reeves said she was "extremely troubled" by China's measures and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "damaging for the international commerce and creates further obstacles."

"I believe there are sectors where we should challenge China, but there are also valuable prospects to export to Chinese markets, including banking sector and other sectors of the economic system. We've got to get that balance right."

The Treasury chief also confirmed she was collaborating with international partners "regarding our own critical minerals plan, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

Reeves also recognized that the cost the National Health Service pays for pharmaceuticals could go up as a result of ongoing discussions with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or canceling projects in the UK, with some attributing the modest returns they are receiving.

Last month, the government science advisor said the price the health service spends on drugs would need to go up to stop companies and pharmaceutical investment departing from the UK.

Reeves informed the BBC: "It has been observed as a result of the pricing regime, that clinical trials, new drugs have not been provided in the United Kingdom in the way that they are in other continental states."

"The objective is to ensure that patients getting care from the NHS are able to access the finest life-saving drugs in the globe. And so we are examining all of that, and... aiming to attract more capital into Britain."